About 20 per cent of the 50 locations within the inaugural intake of the Hong Kong University of Science and Technology’s (HKUST) new graduate medical school in 2028-29 may be reserved for non-local college students, with most anticipated to come back from mainland China, in line with the establishment.
Applicants for the four-year graduate entry-level drugs programme should go a global admission take a look at, with the college preferring these with a background in biotechnology.
According to HKUST, the tutoring payment for holders of a previous bachelor’s diploma pursuing drugs will match that for undergraduate college students, however non-locals can be topic to greater charges.
Nancy Ip Yuk-yu, president of HKUST, stated the college was working in direction of establishing town’s third medical school.
“This innovative medical school combines artificial intelligence, biotechnology and clinical medicine to cultivate a new generation of doctors who embrace technology,” she stated.
Her remarks got here almost 4 months after HKUST received the bid to run the medical school. The college will make investments greater than HK$7 billion (US$894.6 million) within the medical school over the subsequent 25 years, positioning itself to enrich the event of the 2 present ones operated by two native universities.